MedTrace Logo

Safety and Preliminary Efficacy Study of MTS-01 for the Prevention of Alopecia Induced by WHole Brain Radiotherapy

NCT00713154 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2008-07-11

No results posted yet for this study

Summary

The purpose of this study is to determine if MTS-01 is effective in preventing radiotherapy-induced hair loss in patients receiving whole brain radiotherapy

Conditions

Interventions

DRUG

MTS-01

MTS-01 7% gel in 100 ml tubes, two 100 ml tubes prior to each radiation treatment

DRUG

Placebo

Placebo gel in 100 ml tube, two 100 ml tubes prior to each radiation treatment

Sponsors & Collaborators

  • Mitos Pharmaceuticals

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2007-09-30
Completion
2008-09-30

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00713154 on ClinicalTrials.gov